Stelara®
Stelara® (ustekinumab) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation. Specifically it is an interleukin-12 and -23 antagonist antibody, used to treat psoriasis Crohn’s disease and Ulcerative Colitis (UC).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Janssen Biotech |
CLASS: Biologics |
PRESCRIBED BY: Dermatologists |
HOW ADMINISTERED: Injection or IV infusion, or a combination of both (depending on the diagnosis). |
FREQUENCY: For psoriasis, every 12 weeks (after two starter doses); For UC and Crohn’s disease, every eight weeks (after an IV starter dose). |
Length of infusion: ten minutes or less for subcutaneous injection; about 60 mins for IV infusion |
FOR MORE INFORMATION: |
